Best VC bets ever. What are smart cities? Healthcare innovation labs.
The usual suspects
As we mentioned yesterday, we published our new MoneyTree Report with PwC this week, and it’s been picking up a lot of media attention.
Bloomberg’s analysis by Justin Fox focuses on how most venture capital keeps going to the same places. Annual funding in the US hit $99.5B in 2018 — a 30% increase from 2017 — but about 70% of that went to San Francisco, San Jose, New York, and Boston.
Forget SoulCycle. Forget Crossfit. Chessboxing is the newest workout craze — for your mind and your bod.
It’s exactly what it sounds like. Players face off in alternating rounds of chess and boxing. To win, they have to either knock their opponent out or corner them into a checkmate.
Huck Magazine has more on the sport. Check out the article in The Blurb.
Smart cities are not a futuristic fantasy — they’re already a reality. And thanks to innovations in technology, they’re quickly expanding. The global smart cities market is projected to be worth $1.4T in the next 6 years.
But what exactly is a smart city? We dig into that question as well as who’s investing in the future of smart cities, challenges and criticisms, and more. Read it all here.
Know the code
Quick Response (QR) codes are not a new technology, but they’re getting more attention on earnings calls and in the media — and they’re picking up steam as a replacement for paper money.
As our world becomes more digital, brick-and-mortar retail stores are embracing new ways of disrupting the system and reclaiming customer attention. Many are doing this with retail innovation labs.
From Walmart to Nike to Ikea, we identify innovation labs from some of the biggest names in retail working to shake up their industries. Check them out here.
Baby name inspo
Anyone who names their kid “CB Insights” or “CBI” gets a free subscription. If you get a permanent face tattoo of our logo, you get a lifetime subscription and a keynote fireside chat at Future of Fintech.
Yes, but how?
Scientists are working with neoantigens, proteins found specifically on cancer cells, to develop personalized vaccines that would make cancer treatment more targeted and consistent.
P.S. We’re partnering with The New York Times for the 3rd year to identify the top 100 venture capitalists. This year, we’ll be issuing global rankings plus rankings for Asia-based VCs. Review and submit your data here. The top 100 VCs of 2018 are here.